Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Schizophr Res. 2016 Jan 23;171(0):131–136. doi: 10.1016/j.schres.2016.01.021

Table 1.

Demographic and Clinical Features of the Full Sample and the Neurocognitively Impaired Sample

Full Sample (n=214) Neurocognitively Impaired Sample (n=168)
Mean (sd) or % Mean (sd) or %
Age, years 41.2 (12.4) 42.7 (12.3)
Education, years 12.3 (2.2) 12.1 (2.1)
% Male 65.4 67.3
% Caucasian 54.7 51.2
% Hispanic ethnicity 23.4 21.4
% African American 36.0 40.5
% Schizophrenia (vs. Schizoaffective) 58.2 63.0
% Prescribed antipsychotic medication 98.1 98.2
% Living independently 73.3 72.6
% Employed 9.8 10.1
% Never married 53.2 50.3
PANSS positive symptoms total 15.7 (5.5) 16.1 (5.7)
PANSS negative symptoms total 15.7 (6.1) 16.2 (6.3)
BDI-II total 15.3 (11.7) 15.0 (11.6)

Note. BDI-II=Beck Depression Inventory, second edition; PANSS=Positive and Negative Syndrome Scale